Sugi Predict

Sugi Predict / Compounds / SCHEMBL1709548

SCHEMBL1709548

SCHEMBL1709548

CCN(CC)CCCS(=O)(=O)N[C@H](CCc1ccccc1)c1nc(CNC(=O)OC2CCCCC2)n[nH]1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GHSR Q92847 3/20 0.58
▸ GAA P10253 1/20 0.33
▸ CHRM2 P08172 4/20 0.33
▸ CHRM1 P11229 4/20 0.33
▸ CYP3A4 P08684 2/20 0.33
▸ HTR1A P08908 1/20 0.33
▸ ADRA2A P08913 1/20 0.33
▸ DRD1 P21728 1/20 0.33
▸ SLC6A2 P23975 1/20 0.33
▸ ADRA1A P35348 1/20 0.33
▸ OPRM1 P35372 1/20 0.33
▸ DRD3 P35462 1/20 0.33
▸ SLC6A3 Q01959 1/20 0.33
▸ KCNH2 Q12809 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ SCN1A P35498 1/20 0.33
▸ SCN2A Q99250 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1709690 0.99 GHSR (0.59) GHSRGAACHRM2CHRM1CYP3A4
SCHEMBL10121678 0.98 GHSR (0.59) GHSRGAACHRM2CHRM1CYP3A4
SCHEMBL10121682 0.89 GHSR (0.69) GHSRGAACHRM2CHRM1HTR1A
SCHEMBL10121891 0.88 GHSR (0.56) GHSRGAACHRM2CHRM1CYP3A4
SCHEMBL10122118 0.88 GHSR (0.56) GHSRGAACHRM2CHRM1CYP3A4
SCHEMBL10122180 0.88 GHSR (0.57) GHSRGAACHRM2CHRM1CYP3A4
SCHEMBL1709605 0.87 GHSR (0.64) GHSRGAALMNACYP2D6TSHR
SCHEMBL1709719 0.87 GHSR (0.61) GHSRCHRM2CHRM1CYP3A4HTR1A
SCHEMBL1709620 0.87 GHSR (0.56) GHSRGAA
SCHEMBL10121851 0.87 GHSR (0.56) GHSRGAALMNAACHEREN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120088747-A1 SULFONAMIDE CONTAINING COMPOUNDS AND USES THEREOF ELIXIR PHARMACEUTICALS, INC. 2012-04-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088747-A1 SULFONAMIDE CONTAINING COMPOUNDS AND USES THEREOF GHSR, GHRHR, STS GHSR 1/4885GAA 55/4885CHRM2 3885/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.